<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365262">
  <stage>Registered</stage>
  <submitdate>5/11/2013</submitdate>
  <approvaldate>13/11/2013</approvaldate>
  <actrnumber>ACTRN12613001250729</actrnumber>
  <trial_identification>
    <studytitle>Protein-bound uraemic toxins in Peritoneal Dialysis Patients</studytitle>
    <scientifictitle>Removal of selected low molecular weight highly protein-bound uraemic toxins in patients on peritoneal dialysis</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Kidney Failure</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Measurement of protein binding of small molecular weight toxins in peritoneal dialysis effluent assessed on 2 occasions 1 month apart
Measurement is undertaken with an HPLC assay for simultaneous determination of 4 uraemic solutes:P Cresol,P Cresol Sulphate,Indoxyl Sulphate,3-indole-acteic acid based on methods described by Calaf et al:J Chromatogr B Analyt Technol Biomed Life Sci. 879(23):2281-2286.2011</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The degree of protein binding for each of the measured solutes is established by measuring total solute in the PD effluent and then separating protein from the PD effluent and measuring the remaining free level. The difference is the bound solute which is expressed as a percentage of the total
</outcome>
      <timepoint>At baseline and 1 month later</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Bovine Serum albumin is added to the PD effluent at a range of concentrations likely to be achievable with wearable sorbent-based recycling PD. Total,bound and free solutes are measured.This enables the development of a binding curve related to protein concentrations</outcome>
      <timepoint>At baseline and 1 month later</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients on Peritoneal Dialysis</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Peritonitis within 1 month
Excessive co-morbidity</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>The number to be studied, 30,although small, is large enough to cover the spectrum of protein excretion found in patients on PD. We do not expect a wide range of binding results</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration />
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/12/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>28/02/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>John Collins</primarysponsorname>
    <primarysponsoraddress>Dept of Renal Medicine
Auckland City Hospital
Box 92024
Auckland 
1023</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Auckland Hospital Renal Trust Fund</fundingname>
      <fundingaddress>Auckland City Hospital
Box 92024
Auckland 
1023</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study looks at the protein binding of low molecular weight highly protein-bound toxins in Peritoneal Effuent of patients on Peritoneal Dialysis</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern A HDEC</ethicname>
      <ethicaddress>Ministry of Health
No.1 The Terrace
PO Box 5013
Wellington,6011</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>13/11/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>John Collins</name>
      <address>Dept Renal Medicine
Auckland City Hospital
Park Road,Grafton
Auckland,1010
</address>
      <phone>64 9 3797440</phone>
      <fax>64 9 3074987</fax>
      <email>johnco@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John Collins</name>
      <address>Dept Renal Medicine
Auckland City Hospital
Park Road,Grafton
Auckland 1010
</address>
      <phone>64 9 3797440</phone>
      <fax>64 9 3074987</fax>
      <email>johnco@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John Collins</name>
      <address>Dept Renal Medicine
Auckland City Hospital
Park Road,Grafton
Auckland 1010
</address>
      <phone>64 9 3797440</phone>
      <fax>64 9 3074987</fax>
      <email>johnco@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>John Collins</name>
      <address>Dept Renal Medicine
Auckland City Hospital
Park Road, Grafton
Auckland 1010
</address>
      <phone>64 9 3797440</phone>
      <fax>64 9 3074987</fax>
      <email>johnco@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>